Recently, the identification of predictive oncology biomarkers in common carcinomas has led to significant progress in personalized therapy, higher response rates, and clinical benefit. The results from clinical trials utilizing these therapies have resulted in FDA approval of these groundbreaking therapies as standard in oncologic care.
The Angeles Clinic and Research Institute has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments, and expertly guiding and training the next generation of clinicians. We are committed to bringing innovative therapeutic options to all of our patients with cancer. As part of this commitment, our cancer clinical trials program has been expanded to include Experimental Therapeutics (Phase I) Drug Development programs encompassing Translational Research and ImmunoOncology..
Through our oncology clinical trials program, The Angeles Clinic and Research Institute continues our ongoing commitment to offer our patients with cancer excellence in research and patient care. We offer multiple cancer clinical trials in a wide range of cancerous tumors. On behalf of The Angeles Clinic and Research Institute, we thank you for considering these important therapeutic options and look forward to helping you.